Literature DB >> 26408692

GADD34 Facilitates Cell Death Resulting from Proteasome Inhibition.

Lintao Liu1, Sachiko Ito1, Naomi Nishio1, Yang Sun1, Nana Chen1, Yuriko Tanaka1, Ken-Ichi Isobe2.   

Abstract

BACKGROUND: Proteasome inhibition has been proven to be a promising therapeutic strategy in cancer clinical treatment. Inhibition of proteasome leads to failure of amino acid homeostasis, which causes cell death via activation of various mechanisms.
MATERIALS AND METHODS: To investigate the role of GADD34 in cell death following proteasome inhibition, we treated WT MEF and GADD34 KO MEF with MG132 and various analyses were performed, including PI staining, western blot, immunofluorescence and ROS production.
RESULTS: Expression of GADD34 dramatically enhanced MG132-induced cell death via protein synthesis. GADD34 decreased phosphorylated eIF2α and increased ROS production and the levels of ubiquinated protein. Importantly, we found that accumulation of autophagy following MG132-treatment facilitated cell death in MEF.
CONCLUSION: GADD34 plays a vital role in promoting cell death following proteasome inhibition via enhancing protein synthesis to activate death-associated mechanisms, including ER stress, ROS production and autophagy formation. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  GADD34; autophagy; cell death; eIF2α; proteasome inhibition

Mesh:

Substances:

Year:  2015        PMID: 26408692

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.

Authors:  Peiying Song; Songpeng Yang; Hui Hua; Hongying Zhang; Qingbin Kong; Jiao Wang; Ting Luo; Yangfu Jiang
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

2.  Oxidative Stress and Deregulated DNA Damage Response Network in Lung Cancer Patients.

Authors:  Dimitra T Stefanou; Marousa Kouvela; Dimitris Stellas; Konstantinos Voutetakis; Olga Papadodima; Konstantinos Syrigos; Vassilis L Souliotis
Journal:  Biomedicines       Date:  2022-05-26

3.  Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines.

Authors:  Shuai Hu; Yi Jin; Yanghan Liu; Mats Ljungman; Nouri Neamati
Journal:  Eur J Med Chem       Date:  2018-09-15       Impact factor: 6.514

4.  Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.

Authors:  Anna Vert; Jessica Castro; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Oncotarget       Date:  2017-02-14

5.  A Redox-Silent Analogue of Tocotrienol May Break the Homeostasis of Proteasomes in Human Malignant Mesothelioma Cells by Inhibiting STAT3 and NRF1.

Authors:  Kyota Ishii; Momoka Fusegi; Tatsuki Mori; Kosuke Teshima; Nanako Ninomiya; Kakeru Kohno; Ayami Sato; Tatsuya Ishida; Yuichi Miyakoshi; Tomohiro Yano
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

Review 6.  The integrated stress response.

Authors:  Karolina Pakos-Zebrucka; Izabela Koryga; Katarzyna Mnich; Mila Ljujic; Afshin Samali; Adrienne M Gorman
Journal:  EMBO Rep       Date:  2016-09-14       Impact factor: 8.807

7.  Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.

Authors:  Shanliang Zhong; Huanwen Chen; Sujin Yang; Jifeng Feng; Siying Zhou
Journal:  PeerJ       Date:  2020-07-27       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.